Reddit Free cash flow increased by 18.0% to $311.16M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 145.8%, from $126.60M to $311.16M. Over 3 years (FY 2022 to FY 2025), Free cash flow shows an upward trend with a 89.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flow| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$25.06M | -$25.06M | -$25.06M | -$25.06M | $3.72M | -$54.88M | -$11.64M | -$22.04M | $29.21M | $27.18M | $70.27M | $89.16M | $126.60M | $110.83M | $183.10M | $263.64M | $311.16M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +114.8% | <-999% | +78.8% | -89.3% | +232.6% | -6.9% | +158.5% | +26.9% | +42.0% | -12.5% | +65.2% | +44.0% | +18.0% |
| YoY Change | — | — | — | — | +114.8% | -119.0% | +53.6% | +12.1% | +685.5% | +149.5% | +703.7% | +504.6% | +333.4% | +307.7% | +160.6% | +195.7% | +145.8% |